共 50 条
- [42] The Pharmaceutical Industry in 2024: An Analysis of the FDA Drug Approvals from the Perspective of Molecules MOLECULES, 2025, 30 (03):
- [43] The Pharmaceutical Industry in 2022: An Analysis of FDA Drug Approvals from the Perspective of Molecules MOLECULES, 2023, 28 (03):
- [44] An Industry Perspective on Dengue Drug Discovery and Development DENGUE AND ZIKA: CONTROL AND ANTIVIRAL TREATMENT STRATEGIES, 2018, 1062 : 333 - 353
- [45] The Pharmaceutical Industry in 2023: An Analysis of FDA Drug Approvals from the Perspective of Molecules MOLECULES, 2024, 29 (03):
- [46] Biological reactive intermediates in drug discovery and development - A perspective from the pharmaceutical industry BIOLOGICAL REACTIVE INTERMEDIATES VI: CHEMICAL AND BIOLOGICAL MECHANISMS IN SUSCEPTIBILITY TO AND PREVENTION OF ENVIRONMENTAL DISEASES, 2001, 500 : 45 - 51
- [47] A Medicinal Chemist's Perspective on Transitioning from Industry to Academic Drug Discovery ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (05): : 687 - 689
- [48] De Novo Pediatric Development of an Antiviral Drug Product: A Perspective from Industry Drug information journal : DIJ / Drug Information Association, 1999, 33 (2): : 397 - 405